Cereno Scientific's nomination committee proposes Joakim Söderström as new chairman of the board
Cereno Scientific (XSAT: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the nomination committee's proposed resolutions for the 2023 annual general meeting include the new election of Joakim Söderström as chairman of the board. The nomination committee also proposes that the board be consolidated to include five members and no deputies.“Personally, it is very exciting to see how the drug candidate CS1, which my research group discovered had very interesting cardiovascular effects and around which the company was founded,